AXIS Capital (AXS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Net income available to common shareholders was $204 million ($2.40 per diluted share), with operating income of $250 million ($2.93 per diluted share) and annualized operating ROE of 20%.
Gross premiums written reached $2.4 billion, up 7% year-over-year, the highest second quarter ever.
Underwriting income was $161 million, with a combined ratio of 90.4%.
Book value per diluted common share increased to $59.29, up 16% year-over-year and nearly 10% year-to-date.
CEO highlighted strong specialty underwriting, record operating EPS, and continued operational transformation.
Financial highlights
Net investment income rose 40% to $191 million, driven by higher yields and positive returns from alternatives.
G&A expense ratio improved to 11.4% from 13.3% a year ago; year-to-date G&A spend down 7%.
$47 million in catastrophe losses, including $38 million from natural catastrophes and $9 million from the Red Sea conflict.
No prior year reserve development was recognized in Q2 2024; reserve actions from Q4 2023 reinforced by current data.
Total assets stood at $32.1 billion; reserve for losses and loss expenses was $16.7 billion.
Outlook and guidance
Insurance segment annual premium growth guidance remains 7%-12%; reinsurance expected to deliver mid-single-digit growth for the full year.
G&A ratio target below 11% for full year 2026.
Mix shift toward short-tail lines expected to persist through 2024; liability writings to benefit from reinvestment in 2025.
No material change expected in insurance loss ratios for 2024; reinsurance loss ratio expected to remain in mid-60s.
AXIS is positioned for continued profitable growth, supported by a strengthened book and expanding specialty market footprint.
Latest events from AXIS Capital
- Record premiums, 18.3% book value growth, and improved combined ratio marked the year.AXS
Q4 20253 Feb 2026 - Q3 net income was $173M, with record investment income and strong specialty growth.AXS
Q3 202417 Jan 2026 - LPT with Enstar shifts $2.35B in reserves, boosting specialty focus and capital flexibility.AXS
UBS Global Specialty Insurance/Reinsurance Virtual Conference 202411 Jan 2026 - Record 2024 earnings, premium growth, and capital returns with improved profitability.AXS
Q4 20249 Jan 2026 - Orderly CFO transition, selective specialty growth, and data-driven efficiency define the outlook.AXS
KBW Insurance Conference 20255 Jan 2026 - Q1 2025 delivered record EPS, 19.2% ROACE, and strong premium and book value growth.AXS
Q1 202523 Dec 2025 - 2024 saw record growth, strong governance, and expanded ESG, with key votes on directors and pay.AXS
Proxy Filing2 Dec 2025 - Specialty-driven growth, strong governance, and ESG leadership define the 2025 proxy agenda.AXS
Proxy Filing2 Dec 2025 - Director elections, executive pay, and auditor appointment up for vote at the 2025 meeting.AXS
Proxy Filing2 Dec 2025